Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Green Med Solution (BGMS) Short-term Investments (2018 - 2022)

Historic Short-term Investments for Bio Green Med Solution (BGMS) over the last 6 years, with Q4 2022 value amounting to $4.5 million.

  • Bio Green Med Solution's Short-term Investments rose 156.35% to $4.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $4.5 million, marking a year-over-year increase of 156.35%. This contributed to the annual value of $4.5 million for FY2022, which is 156.35% up from last year.
  • Bio Green Med Solution's Short-term Investments amounted to $4.5 million in Q4 2022, which was up 156.35% from $4.5 million recorded in Q4 2021.
  • Bio Green Med Solution's 5-year Short-term Investments high stood at $16.7 million for Q4 2018, and its period low was $4.5 million during Q4 2021.
  • Its 4-year average for Short-term Investments is $7.8 million, with a median of $4.9 million in 2020.
  • As far as peak fluctuations go, Bio Green Med Solution's Short-term Investments tumbled by 1594.07% in 2021, and later surged by 156.35% in 2022.
  • Over the past 4 years, Bio Green Med Solution's Short-term Investments (Quarter) stood at $16.7 million in 2018, then plummeted by 68.08% to $5.3 million in 2020, then fell by 15.94% to $4.5 million in 2021, then increased by 1.56% to $4.5 million in 2022.
  • Its last three reported values are $4.5 million in Q4 2022, $4.5 million for Q4 2021, and $5.3 million during Q4 2020.